Key points: CarMax stock fell despite the company’s revenues surging 48.8% to $7.7bn. Investors ignored the news in a classic ‘buy the rumor, sell the news' event. S

Key points: Biodesix stock soared 85.5% in a delayed response to recent events. The company recently raised $11.7 million to fund its future growth. Investors are bu

Key points: PolarityTE could lose it’s NASDAQ quotation Something must be done and doing something might increase value A reverse Stock split might do it so is this the ex

Key points: First Tin has just started trading in London Trading is thin, obviously - 5 trades in one hour this morning They’ve definitely got tin, but is it worth it?

Key points: Oriole Resources shares rallied 8.6% on a £403K rebate from HMRC. Investors cheered the news since it is an income source for Oriole. The company’s proje

Key points: Given the revival of air travel, we’d expect Rolls-Royce to be doing well That isn’t how informed opinion has it though JPMorgan has just downgraded RR shares

Key points: Novacyt shares fell despite the UK approving its second COVID-19 test. Investors were largely unimpressed by the achievement due to various reasons. The

Key points: An analyst at HSBC calls Easyjet the cheapest of the London listed airlines The undervaluation is claimed to be about 30% The rest of the market doesn’t agree,

Key points: Is the Miami crypto bull offensive? Well, the jury is still out on that… The crypto industry is facing multiple challenges that it must overcome. So what

Key points: The crypto market has fallen significantly today and since April began. There are multiple factors behind the decline, which will likely persist. However

Key points: SAIL shares jumped 30% following $6.12B acquisition from Thoma Bravo Remote working trends and Russian cyber attacks have increased focus on cybersecurity

Key points: NIO stock dropped as much as 9% this morning on news of production suspension The company also lags behind the wider Chinese EV market How will Nio stand

Key points: Veru shares soared around 30% on overwhelming 'efficacy' of novel Covid-19 drug Phase 3 trial was cut short due to evident efficacy and no clear safety concerns

Key points: NVDA shares have sold off over 13% in the last week, trading down a further 4% this morning Macro concerns coupled with a reaction to the Fed are leaving tech stocks

Key points: The AT&T stock price fell 23% premarket this morning The actual change in the AT&T stock price was up 1.3%. This is a result of the Warner Brothers Discovery,

Key points: A rental agreement is not a sale, we should all agree on that Still, market penetration is market penetration Hyzon Motors will ship 18 hydrogen tricks to Hyla

Key points: UOG shares edged higher after completing the sale of UOG Italia. The company sold its Italian unit for a total consideration of over €2.1m. Investors are

Key points: Sareum share rallied 12.3% on the European patent grant for SDC-1802 As a result, the biotech firm’s shares have rallied by 52.72% in one week What could happe

Key points: Amigo Holdings has a certain problem - will it survive? It’s possible that compensation for past lending will mean it won’t But if that can be capped, then the